ZA966842B - Transdermal administration of vorozole. - Google Patents

Transdermal administration of vorozole.

Info

Publication number
ZA966842B
ZA966842B ZA9606842A ZA966842A ZA966842B ZA 966842 B ZA966842 B ZA 966842B ZA 9606842 A ZA9606842 A ZA 9606842A ZA 966842 A ZA966842 A ZA 966842A ZA 966842 B ZA966842 B ZA 966842B
Authority
ZA
South Africa
Prior art keywords
vorozole
transdermal administration
transdermal
administration
Prior art date
Application number
ZA9606842A
Inventor
Marcus Joannes Maria Noppe
Theo Cesar Garrevoet
Joze Peeters
Jean Louis Mesens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA966842B publication Critical patent/ZA966842B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9606842A 1995-08-14 1996-08-13 Transdermal administration of vorozole. ZA966842B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95202204 1995-08-14

Publications (1)

Publication Number Publication Date
ZA966842B true ZA966842B (en) 1998-02-16

Family

ID=8220567

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606842A ZA966842B (en) 1995-08-14 1996-08-13 Transdermal administration of vorozole.

Country Status (4)

Country Link
AR (1) AR003979A1 (en)
AU (1) AU6821196A (en)
WO (1) WO1997006788A1 (en)
ZA (1) ZA966842B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302289B1 (en) 1998-09-30 2000-09-05 Univ Catania PHARMACEUTICAL COMPOSITIONS WITH ANTINEOPLASTIC ACTIVITY
US6277401B1 (en) * 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
JP2003518009A (en) * 1999-07-06 2003-06-03 ザ、プロクター、エンド、ギャンブル、カンパニー Sheet member
AU3246000A (en) * 1999-07-06 2001-01-22 Procter & Gamble Company, The Cosmetic or dermapharmaceutical patch
DE10042411A1 (en) * 2000-08-30 2002-03-28 Lohmann Therapie Syst Lts Transdermal therapeutic system for the delivery of exemestane
AU2004220541B2 (en) 2003-03-12 2009-03-26 Epitome Pharmaceuticals Limited Rapidly absorbing lipophilic skin compositions and uses therefor
DE102007032468A1 (en) * 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermal therapeutic systems containing the active substance anastrozole
DE102010046464A1 (en) 2009-03-19 2011-04-21 Amw Gmbh Transdermal system, useful for indicating breast cancer in postmenopausal women, comprises aromatase inhibitor, drug-impermeable skin protective layer, reservoir, optional drug-permeable membrane and a carrier for reservoir or membrane
DE102010026883A1 (en) 2010-03-11 2011-12-15 Amw Gmbh Transdermal system useful e.g. for indication of breast cancer with progesterone-receptor positive status, comprises e.g. aromatase inhibitor, active substance puller protection layer, active substance reservoir

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0165781A1 (en) * 1984-06-18 1985-12-27 Eli Lilly And Company Aromatase inhibiting N-substituted imidazole derivatives
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
GB2256135B (en) * 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
JP2700595B2 (en) * 1992-05-21 1998-01-21 呉羽化学工業株式会社 Anti-aromatase agent containing azole derivative

Also Published As

Publication number Publication date
AU6821196A (en) 1997-03-12
WO1997006788A1 (en) 1997-02-27
AR003979A1 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
AU5397996A (en) Iontophoretic transdermal system for the administration of at least two substances
GB9505491D0 (en) Therapeutic agents
GB9513118D0 (en) Therapeutic agents
GB9513117D0 (en) Therapeutic agents
GB9505492D0 (en) Therapeutic agents
EP0941039A4 (en) Transdermal administration of ment
GB9512290D0 (en) Uses of polyhexanide
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
GB9507291D0 (en) Therapeutic agents
ZA965922B (en) Preparation of N-substituted 3-hydroxypyrazoles.
ZA974148B (en) Administration of histamine for therapeutic purposes.
GB9507348D0 (en) Therapeutic agents
GB9500580D0 (en) Therapeutic agents
ZA966842B (en) Transdermal administration of vorozole.
GB9501865D0 (en) Therapeutic agents
ZA96796B (en) Transdermal formulation.
CY2388B1 (en) Rate-controlled transdermal administration of risperidone.
ZA965494B (en) Therapeutic agents.
GB9524942D0 (en) Drug therapy
EP0668759A4 (en) Transdermal delivery of ketorolac.
AU1143899A (en) Transdermal delivery of 3,4-diarylchromans
ZA966083B (en) Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
GB2300121B (en) Complete infusion set
GB2304046B (en) Diabetes therapy
ZA97322B (en) Therapeutic use of d-threo-methylphenidate.